Navigation Links
Pfizer, Genentech, Amgen, Bayer, Wyeth, Abbott, Merck and Additional Leading Pharmaceutical Companies Participating During ExL Pharma's Fall Line Up!
Date:12/20/2007

NEW YORK, Aug. 10 /PRNewswire/ -- ExL Pharma is pleased to announce the fall conference line up which covers many of the leading issues that are impacting the pharmaceutical industry today. The events that are currently scheduled offer educational and networking opportunities for Clinical, Marketing, R&D, and Medical Affairs executives from large to small pharmaceutical, biotech and medical technology companies.

Listed below are details on some of the featured events and highlights from those conferences:

September 10-11th, Philadelphia, PA

3rd Clinical Performance Metrics & Benchmarking- Measuring and Improving

Clinical Performance to Maximize Efficiency

The 2007 Metrics event features 5 Case Study examples from Pfizer, Merck,

Allergan, Astrazeneca, and Sanofi-Aventis on different clinical

performance measurement applications.

September 13-14th, San Francisco, CA

6th Investigator-Initiated Trials- Ensuring Quality Studies through

Increased Collaboration,

Participate in the first ever IIT working group and help shape best

practices and form future guidelines.

September 24-25th, Annapolis, MD

3rd Merging EHR & eClinical Technologies- Implementing the Technology for

Convergence

This event features presentations from Pfizer, Allscripts, Johnson &

Johnson, HL7 and CDISC discussing strategies for integrating drug

development and healthcare IT.

October 22-24, Princeton, NJ

Digital Pharma- Accelerating to the Next Generation of Marketing with Web

2.0

Hear leading pharmaceutical companies such as Abbott, Wyeth and Bayer

discuss how they are taking full advantage of Web 2.0 marketing strategies

to communicate with consumers and physicians.

November 5-6th, Princeton, NJ

3rd Pharmaceutical Meeting Planners Summit- The Ideal Networking

Environment for Pharmaceutical Meeting Planners

This newly updated
'/>"/>

SOURCE ExL Pharma
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. KineMed to Collaborate With Merck KgaA to Validate New Applications for Drug Development Candidates
2. ZymoGenetics and Merck Serono Receive FDA Special Protocol Assessment for Atacicept Pivotal Study in Lupus Nephritis
3. Merck Will Obtain Blockbuster Antidiabetic Drug Sales in Type 2 Diabetes Market by 2011
4. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
5. NeoMatrix Announces Additional Funding for Breakthrough Breast Cancer Screening Test
6. Astellas and Theravance Report Additional Telavancin Data at 47th Annual ICAAC
7. PTC Therapeutics Announces Encouraging Additional Phase 2 Results of PTC124 in Cystic Fibrosis
8. AMDL Expands Drug Distribution in China With Additional Agreement, Valued at $2.3 Million Annually
9. NASDAQ Panel Grants Merge Technologies Additional Time to Regain Compliance
10. iCAD, Inc. Awarded Two Additional Patents for Its Computer-Aided Detection Technology
11. Neurocrine Receives Approvable Letter for Indiplon Capsules with Additional Safety and Efficacy Data Required by FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... May 28, 2015 The Academy of Model ... Aviation Day on August 15, 2015. National Model Aviation Day ... and to introduce model flying to the general public. , ... clubs to participate in the celebration by hosting events in ... host National Model Aviation Day events. View our online ...
(Date:5/28/2015)... CARLOS, Calif. , May 28, 2015 /PRNewswire/ ... testing, today announced a study published in ... the Panorama single-nucleotide polymorphism (SNP)-based non-invasive prenatal test ... the first trimester. A study ... that complete molar pregnancies occur in about 1 ...
(Date:5/28/2015)... May 28, 2015 BioNorth Texas ... and representing the life sciences industry in northern ... Directors meeting at The Foundry in Dallas on ... organization brought together a broad spectrum of biotech ... the organization's early successes in partnering with key ...
(Date:5/28/2015)... Mass. , May 28, 2015 RXi ... focused on discovering and developing innovative therapeutics, primarily in ... pricing of a public offering of 26 million units ... share for gross proceeds of approximately $10.4 million. Each ... (ii) a 13-month overallotment purchase right to purchase 0.50 ...
Breaking Biology Technology:Model flying pilots celebrate the Academy of Model Aeronautics Foundation’s Third Annual National Model Aviation Day 2First Confirmed Detection of a Complete Molar Pregnancy with Cell-Free DNA Test 2First Confirmed Detection of a Complete Molar Pregnancy with Cell-Free DNA Test 3BioNorthTX Holds Inaugural Board of Directors Meeting 2BioNorthTX Holds Inaugural Board of Directors Meeting 3RXi Pharmaceuticals Announces $10 Million Public Offering of Common Stock and Warrants 2RXi Pharmaceuticals Announces $10 Million Public Offering of Common Stock and Warrants 3
... 2011 PharmAthene, Inc. (NYSE Amex: PIP ... and chemical threats, today announced the appointment of Brian ... September 22, 2011. Mr. Markison was recently ... Officer for Nycomed U.S. which will be spun out from the ...
... Inc., a biopharmaceutical company focused on the development of ... today that it presented positive results from a Phase ... severe chronic obstructive pulmonary disease (COPD), a large and ... the annual meeting of the European Respiratory Society (ERS). ...
... - Clean solutions to human energy demands are essential to ... energy at our disposal, we have yet to learn how ... to University of Toronto chemistry professor Greg Scholes, the answers ... nature. "Solar fuel production often starts with the energy ...
Cached Biology Technology:PharmAthene Appoints Brian A. Markison to the Company's Board of Directors 2PharmAthene Appoints Brian A. Markison to the Company's Board of Directors 3Elevation Pharmaceuticals Presents Positive Phase 2a Results in COPD Patients at the European Respiratory Society Annual Congress 2Elevation Pharmaceuticals Presents Positive Phase 2a Results in COPD Patients at the European Respiratory Society Annual Congress 3Elevation Pharmaceuticals Presents Positive Phase 2a Results in COPD Patients at the European Respiratory Society Annual Congress 4Elevation Pharmaceuticals Presents Positive Phase 2a Results in COPD Patients at the European Respiratory Society Annual Congress 5Nature offers key lessons on harvesting solar power, says U of T chemistry professor 2
(Date:4/27/2015)... ATLANTA , April 27, 2015  For more ... and trade show has been the premier worldwide event ... Systems 2015 is a must-attend event for any local, ... insight into the emerging commercial markets and current applications ... and innovations of this projected $48 billion industry, and ...
(Date:4/20/2015)... The announcement comes as demand for fire vault ... Ireland,s foremost records management company, has secured ... impressive track record of clients within the first 12 months, ... sector in Dubai . As a result, ... a further eight staff members at its Irish headquarters. The ...
(Date:4/13/2015)... , April 13, 2015  higi, a leading ... ways to more fully engage with their communities around ... industry-leading, privacy protected and secure API.  ... enables the most accessible, affordable, and convenient vehicle to ... The API will allow ...
Breaking Biology News(10 mins):UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3
... by St. Jude Children,s Research Hospital scientists has identified ... targeting an innate immune system component in a bid ... researchers demonstrated that the primary function of one of ... in turn dampens the immune response to infections and ...
... -- Researchers at Georgetown Lombardi Comprehensive Cancer Center have ... determinant of resistance to anti-estrogen therapy used to treat ... the July 1 issue of Cancer Research , ... breast cells undergo stress induced by the agents tamoxifen ...
... month,s Physics World, Steve Haake, director of the Centre for ... that the men,s 100 m sprint will be one event ... called the "performance-improvement index", which uses very simple physics to ... over the last 100 years. The model shows that ...
Cached Biology News:Innate immune system protein provides a new target in war against bacterial infections 2Innate immune system protein provides a new target in war against bacterial infections 3Single protein promotes resistance to widely used anti-estrogen drugs 2Single protein promotes resistance to widely used anti-estrogen drugs 3Physics confirms sprinters are performing better than ever before 2
... siRNA while maintaining high cell viability ... simultaneously , Fast: less than ... incubation , Highly reproducible results ... use with the Bio-Rad Gene Pulser Xcell ...
100 adhesive strips....
Request Info...
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Biology Products: